OR WAIT null SECS
July 25, 2022
A joint statement calling for international collaboration on the creation and use of real-world evidence has been published by the International Coalition of Medicines Regulatory Authorities.
July 18, 2022
The European Medicines Agency guidance highlights key principles and examples of good practices to prevent and manage shortages of human medicines.
July 02, 2022
Dame Deborah James’ legacy and the millions raised through her campaigning will undoubtedly be a big boost to clinical research, ultimately providing new and promising treatments for bowel cancer patients.
June 29, 2022
The European Commission has approved Cosentyx for the treatment of various childhood arthritic conditions.
The European Commission has approved Xenpozyme as the first treatment for ASMD.
June 27, 2022
The Sanofi-GSK vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial with a high-Omicron environment.
Lonza will produce drug product for Pierre Fabre’s monoclonal antibody W0180.
The partnership between Echosens and Novo Nordisk is intended to increase awareness and early diagnosis of non-alcoholic steatohepatitis (NASH).
The new guidance outlines the approach the MHRA intends to take for products approved or pending in a decentralized procedure or mutual recognition procedures.
June 24, 2022
Novartis will endorse the Kigali Declaration on neglected tropical diseases and invest $250 million for R&D.